NIAID (National Institute of Allergy and Infectious Diseases)
Scientific/Medical Group Awards
In recognition of exceptional conduct of the HPTN 083 & HPTN 084 clinical trials that resulted in FDA approval of Cabotegravir Long Acting (CAB LA).
Administrative Group Awards
For extraordinary dedication and teamwork in supporting the Department of Health and Human Service's Ending the HIV Epidemic initiative to inform best practices through research.